JP2023538610A5 - - Google Patents
Info
- Publication number
- JP2023538610A5 JP2023538610A5 JP2023512165A JP2023512165A JP2023538610A5 JP 2023538610 A5 JP2023538610 A5 JP 2023538610A5 JP 2023512165 A JP2023512165 A JP 2023512165A JP 2023512165 A JP2023512165 A JP 2023512165A JP 2023538610 A5 JP2023538610 A5 JP 2023538610A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- pharmaceutically acceptable
- composition according
- acceptable salt
- fatty acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063068263P | 2020-08-20 | 2020-08-20 | |
| US63/068,263 | 2020-08-20 | ||
| PCT/US2021/046556 WO2022040346A1 (en) | 2020-08-20 | 2021-08-18 | Compositions and methods for mood enhancement |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023538610A JP2023538610A (ja) | 2023-09-08 |
| JP2023538610A5 true JP2023538610A5 (https=) | 2024-08-26 |
| JP7829552B2 JP7829552B2 (ja) | 2026-03-13 |
Family
ID=80323688
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023512165A Active JP7829552B2 (ja) | 2020-08-20 | 2021-08-18 | 気分を高めるための組成物及び方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230381127A1 (https=) |
| EP (1) | EP4199751A4 (https=) |
| JP (1) | JP7829552B2 (https=) |
| AU (1) | AU2021329909A1 (https=) |
| CA (1) | CA3189188A1 (https=) |
| WO (1) | WO2022040346A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3908374A4 (en) | 2019-01-09 | 2022-12-28 | Epitracker, Inc. | COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF NEURODEGENERATIVE DISEASES |
| JP7404382B2 (ja) | 2019-03-04 | 2023-12-25 | エピトラッカー インコーポレイテッド | 脂肪酸アナログ、ならびに認知機能障害、行動症状および慢性疼痛の処置におけるそれらの使用 |
| EP4426130A1 (en) | 2021-11-03 | 2024-09-11 | Epitracker, Inc. | Pentadecanoylcarnitine for treatment of conditions related to the quality of aging and longevity |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2198661T3 (es) * | 1998-01-21 | 2004-02-01 | Fideline | Composiciones que contienen feromonas para disminuir el estres, la ansiedad y la agresividad en los cerdos. |
| BR9917806B1 (pt) * | 1998-01-21 | 2013-06-18 | composiÇço de feromona para tratamento de estresse ou ansiedade em mamÍferos, e soluÇço. | |
| FR2931676B1 (fr) * | 2008-05-30 | 2011-01-14 | Ceva Sante Animale | Nouveaux modes d'administration d'un melange d'acides gras pour le traitement de mammiferes non humains |
| KR20120129898A (ko) * | 2009-12-30 | 2012-11-28 | 베일러 리서치 인스티튜트 | 알츠하이머 질환 및 노화 뇌를 위한 보충대사 치료요법 |
| US9295637B2 (en) * | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Compositions and methods for affecting mood states |
| US10307388B2 (en) * | 2016-12-29 | 2019-06-04 | The United States Of America As Represented By The Secretary Of The Navy | Compositions and methods for diagnosis and treatment of inflammation |
| AU2019274431B2 (en) * | 2018-05-23 | 2025-03-13 | Epitracker, Inc. | Compositions and methods for diagnosis and treatment of conditions related to the quality of aging and longevity |
| KR102087634B1 (ko) * | 2018-10-11 | 2020-03-11 | (주)바이텍 | 항비만용 조성물 |
-
2021
- 2021-08-18 EP EP21859083.4A patent/EP4199751A4/en active Pending
- 2021-08-18 WO PCT/US2021/046556 patent/WO2022040346A1/en not_active Ceased
- 2021-08-18 CA CA3189188A patent/CA3189188A1/en active Pending
- 2021-08-18 AU AU2021329909A patent/AU2021329909A1/en active Pending
- 2021-08-18 JP JP2023512165A patent/JP7829552B2/ja active Active
-
2023
- 2023-02-16 US US18/170,379 patent/US20230381127A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Valenzuela et al. | Supplements with purported effects on muscle mass and strength | |
| JP2021522203A (ja) | ベータ−ヒドロキシブチレートおよびアセトアセテートを用いたケト積重のための組成物および方法 | |
| CN104780781B (zh) | 调节心理应激个体的皮质酮水平的方法 | |
| JP2023538610A5 (https=) | ||
| ES2203962T3 (es) | Nueva utilizacion de fosfolipidos de origen animal en terapeutica y/o dietetica. | |
| CN103517711B (zh) | 可用于治疗脂质代谢障碍的组合物 | |
| EP3305083A1 (en) | Lipid-containing compositions and methods of use thereof | |
| AU2020221569B2 (en) | Racemic beta-hydroxybutyrate mixed salt-acid compositions and methods of use | |
| HK1042441A1 (zh) | Pufa增补剂 | |
| JP2015221033A (ja) | 授乳女性のための栄養組成物 | |
| JP2023105154A (ja) | がん細胞のｐＡＭＰＫαまたはＣＯＸ－２の含有量を調節するための薬剤の調製のための増感剤の使用 | |
| CA2703042A1 (en) | Formulation to improve gastrointestinal function | |
| AU2025263817A1 (en) | S-beta-hydroxybutyrate compounds and compositions enriched with S- enantiomer | |
| JP7206223B2 (ja) | パーキンソン病の予防および／または支持治療処置のための物質 | |
| JP5418956B2 (ja) | 総合栄養組成物 | |
| JP4603269B2 (ja) | 生理活性のない高分散型基質上で乾燥させた馬乳濃縮物の使用 | |
| JP2019510745A5 (https=) | ||
| JP2016525134A (ja) | チグリンアルデヒドを使用する組成物及び方法 | |
| JP6368368B2 (ja) | ｐ−アニスアルデヒドを使用する組成物及び方法 | |
| US20260034057A1 (en) | Orodispersible tablet, in particular for use as a food supplement | |
| JP6935994B2 (ja) | ケトン体生成促進用組成物 | |
| CA3166226C (en) | Enantiomerically pure r-beta-hydroxybutyrate mixed salt-acid compositions | |
| Mischoulon et al. | Supplements and natural remedies for depression | |
| Holečková et al. | Effect of a 3-month nutritional intervention with a high protein omega 3-enriched oral nutritional supplement on selected anthropometric and laboratory parameters and muscle strength in oncology patients | |
| JP2016525133A (ja) | クミンアルデヒドを使用する組成物及び方法 |